Compare ARK Genomic Revolution ETF (ARKG) vs Enbridge Inc (ENB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Enbridge Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while Enbridge Inc trades at $51.8 (market cap $112.62B). The key difference: Enbridge Inc pays a 5.34% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Enbridge Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | ENB | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $44.55 | $58.04 |
52-Week Low | $24.02 | $45.23 |
Market Cap | — | $112.62B |
Enterprise Value | — | $196.53B |
Dividend Yield | — | 5.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →
